CIK 0001829635 · <br>Emerging growth company
Transcode Therapeutics, Inc.
Sign in to watch- Ticker
- RNAZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811065054
- Phone
- 857-301-6857
- Business address
- 6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
- S-3 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- DEFA14A Proxy Proxy Materials
- 8-K/A Event Material agreement
- SCHEDULE 13D Stake Beneficial Ownership Report
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- 8-K/A Event Material agreement
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 4 of 17 · 324 filings